NCT00576238View on ClinicalTrials.gov

Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

February 29, 2008

Conditions
Atopic Eczema
Interventions
DRUG

betamethasone valerate

Topical application according to a fixed schedule for three weeks

DRUG

betamethasone valerate

Topical application according to a fixed schedule for three weeks

DRUG

urea

Topical application twice daily for up to 6 months

Trial Locations (5)

11486

Sophiahemmet, Stockholm

13183

Nacka hudmottagning, Nacka

Nacka närsjukhus, Nacka

16862

Läkarhuset Vällingby, Vällingby

18288

Hudkliniken, Danderyds sjukhus, Stockholm

All Listed Sponsors
lead

ACO Hud Nordic AB

INDUSTRY

NCT00576238 - Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser | Biotech Hunter | Biotech Hunter